Learn More
INTRODUCTION Men with erectile dysfunction (ED) are typically older and have one or more underlying cardiovascular conditions. AIM To determine the efficacy and safety of a new orodispersible(More)
This double-blind, randomised placebo-controlled, multicentre study evaluated the efficacy, tolerability and safety of 12 weeks' treatment with controlled release darifenacin 15 mg once daily (qd),(More)
AIMS The aim of this study was to investigate the efficacy and safety of 10 mg vardenafil orodispersible tablet (ODT) vs. placebo in a general population of men with erectile dysfunction (ED). (More)
PURPOSE We contrasted the endocrinological and biochemical efficacies of abarelix depot, a pure gonadotropin-releasing hormone antagonist, with a prospective concurrent control cohort receiving(More)